On January 1, 2016 Penn acquired 100% of Teller. The transaction was not a bargain purchase. On the acquisition date, it was determined that Teller had internally-generated patents with a fair value of $83,661,335 that had not been recorded on its financial statements, in accordance with GAAP.

The patents were estimated to have a remaining useful life of 15 years as of the acquisition date. What amount should be reported on Teller's consolidated financial statements as of 12/31/2021 for these patents?